On-Demand Medical Testing
May 21, 2016
Brandon Johnson, founder and president of Boston Microfluidics, shares why his single-drop, self-administered blood test device has been called the Netflix of medical testing. Despite solid results, Johnson reveals the hurdles to securing venture capital financing given the risks of FDA approval. Johnson is now taking his product to market overseas to help screen the heavily infected Egyptian population for hepatitis C.
LISTEN (full-length interview)
DOWNLOAD from iTunes (as aired)
WATCH (on YouTube)
Bill Frezza 
Leave a comment